| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 85 | 2024 | 11107 | 3.950 |
Why?
|
| Receptors, Androgen | 25 | 2024 | 1079 | 3.090 |
Why?
|
| Polymorphism, Single Nucleotide | 82 | 2024 | 15908 | 2.070 |
Why?
|
| Chromosomes, Human, Pair 8 | 13 | 2020 | 453 | 2.070 |
Why?
|
| Genetic Predisposition to Disease | 83 | 2024 | 17878 | 2.060 |
Why?
|
| Genome-Wide Association Study | 54 | 2024 | 12661 | 1.980 |
Why?
|
| Quantitative Trait Loci | 22 | 2024 | 2112 | 1.880 |
Why?
|
| Gene Expression Regulation, Neoplastic | 31 | 2024 | 8542 | 1.510 |
Why?
|
| Carcinoma, Renal Cell | 14 | 2024 | 3164 | 1.250 |
Why?
|
| Enhancer Elements, Genetic | 14 | 2024 | 1360 | 1.120 |
Why?
|
| Epigenomics | 10 | 2024 | 942 | 1.100 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 4 | 2022 | 164 | 1.060 |
Why?
|
| Neuroendocrine Tumors | 3 | 2024 | 641 | 1.020 |
Why?
|
| Kidney Neoplasms | 15 | 2024 | 4252 | 0.980 |
Why?
|
| Alleles | 26 | 2023 | 6861 | 0.970 |
Why?
|
| Germ-Line Mutation | 10 | 2022 | 1852 | 0.930 |
Why?
|
| Ovarian Neoplasms | 17 | 2024 | 4849 | 0.880 |
Why?
|
| Prostate | 12 | 2023 | 1773 | 0.850 |
Why?
|
| Histone Code | 2 | 2021 | 158 | 0.840 |
Why?
|
| Breast Neoplasms | 39 | 2022 | 20988 | 0.840 |
Why?
|
| Chromatin | 11 | 2024 | 2955 | 0.830 |
Why?
|
| Neoplasms, Glandular and Epithelial | 5 | 2022 | 487 | 0.800 |
Why?
|
| Carcinoma, Neuroendocrine | 3 | 2024 | 339 | 0.780 |
Why?
|
| Cell Line, Tumor | 33 | 2024 | 16968 | 0.740 |
Why?
|
| Genetic Loci | 10 | 2017 | 2624 | 0.730 |
Why?
|
| Genes, BRCA2 | 3 | 2021 | 590 | 0.680 |
Why?
|
| Genetic Association Studies | 9 | 2021 | 2734 | 0.640 |
Why?
|
| Haplotypes | 17 | 2011 | 2713 | 0.610 |
Why?
|
| Neoplasms, Hormone-Dependent | 3 | 2011 | 410 | 0.600 |
Why?
|
| Neoplasms | 16 | 2023 | 22131 | 0.590 |
Why?
|
| Chromosome Mapping | 15 | 2020 | 4611 | 0.580 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2022 | 988 | 0.540 |
Why?
|
| Gene Amplification | 5 | 2019 | 1087 | 0.520 |
Why?
|
| DNA Methylation | 7 | 2024 | 4392 | 0.510 |
Why?
|
| Genetic Variation | 19 | 2022 | 6561 | 0.510 |
Why?
|
| Humans | 246 | 2024 | 760740 | 0.510 |
Why?
|
| Male | 140 | 2024 | 360402 | 0.490 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 4 | 2010 | 127 | 0.480 |
Why?
|
| Epigenesis, Genetic | 10 | 2024 | 3794 | 0.470 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2015 | 367 | 0.470 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 6 | 2023 | 790 | 0.460 |
Why?
|
| Carboplatin | 1 | 2017 | 793 | 0.460 |
Why?
|
| Genotype | 31 | 2019 | 12977 | 0.440 |
Why?
|
| Androgen Antagonists | 6 | 2022 | 1409 | 0.440 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2010 | 1932 | 0.430 |
Why?
|
| Androgens | 6 | 2022 | 1285 | 0.420 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2012 | 61 | 0.400 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2012 | 92 | 0.400 |
Why?
|
| Estrogen Receptor beta | 2 | 2010 | 168 | 0.400 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2024 | 2821 | 0.400 |
Why?
|
| Case-Control Studies | 30 | 2024 | 22153 | 0.390 |
Why?
|
| DNA, Neoplasm | 3 | 2015 | 1743 | 0.390 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 4 | 2010 | 416 | 0.390 |
Why?
|
| Pyrophosphatases | 1 | 2012 | 142 | 0.390 |
Why?
|
| Germ Cells | 4 | 2022 | 634 | 0.380 |
Why?
|
| Genetic Markers | 6 | 2019 | 2601 | 0.380 |
Why?
|
| Prostatic Secretory Proteins | 1 | 2010 | 24 | 0.370 |
Why?
|
| Acetylation | 4 | 2023 | 1055 | 0.360 |
Why?
|
| Linkage Disequilibrium | 15 | 2020 | 1994 | 0.360 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2010 | 61 | 0.350 |
Why?
|
| Inositol | 1 | 2011 | 215 | 0.350 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2011 | 702 | 0.350 |
Why?
|
| Genes, myc | 2 | 2022 | 390 | 0.350 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2011 | 99 | 0.340 |
Why?
|
| Risk | 16 | 2020 | 9603 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2010 | 277 | 0.340 |
Why?
|
| Genetics, Population | 6 | 2010 | 935 | 0.340 |
Why?
|
| Mutation | 16 | 2024 | 30015 | 0.340 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2011 | 187 | 0.340 |
Why?
|
| Gene Expression Profiling | 8 | 2021 | 9417 | 0.330 |
Why?
|
| BRCA2 Protein | 3 | 2020 | 797 | 0.320 |
Why?
|
| Breast | 2 | 2013 | 1963 | 0.320 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2020 | 473 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2009 | 418 | 0.320 |
Why?
|
| Transcription Factors | 11 | 2023 | 12116 | 0.300 |
Why?
|
| Aged | 77 | 2024 | 169092 | 0.300 |
Why?
|
| Homeodomain Proteins | 4 | 2022 | 2413 | 0.300 |
Why?
|
| Genetic Research | 4 | 2009 | 171 | 0.300 |
Why?
|
| Frontal Lobe | 4 | 2001 | 1418 | 0.300 |
Why?
|
| BRCA1 Protein | 4 | 2020 | 1149 | 0.300 |
Why?
|
| Histones | 7 | 2021 | 2577 | 0.290 |
Why?
|
| Carcinoma | 4 | 2017 | 2328 | 0.290 |
Why?
|
| Risk Factors | 40 | 2024 | 74128 | 0.280 |
Why?
|
| DNA Repair | 5 | 2021 | 2043 | 0.280 |
Why?
|
| Image Enhancement | 2 | 2009 | 2881 | 0.280 |
Why?
|
| Lung Neoplasms | 10 | 2024 | 13383 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 6 | 2024 | 5780 | 0.270 |
Why?
|
| Polymorphism, Genetic | 6 | 2012 | 4242 | 0.270 |
Why?
|
| Early Detection of Cancer | 2 | 2020 | 3196 | 0.270 |
Why?
|
| Gadolinium DTPA | 2 | 2009 | 823 | 0.270 |
Why?
|
| Nanomedicine | 1 | 2009 | 289 | 0.270 |
Why?
|
| Estrogen Receptor alpha | 1 | 2010 | 583 | 0.260 |
Why?
|
| Middle Aged | 75 | 2024 | 220603 | 0.260 |
Why?
|
| Technology, Radiologic | 1 | 2006 | 160 | 0.260 |
Why?
|
| Selection, Genetic | 1 | 2010 | 868 | 0.260 |
Why?
|
| Cohort Studies | 30 | 2021 | 41464 | 0.260 |
Why?
|
| Interleukin-7 | 2 | 2022 | 143 | 0.250 |
Why?
|
| Adenocarcinoma | 3 | 2021 | 6345 | 0.250 |
Why?
|
| Gene Expression | 4 | 2014 | 7569 | 0.240 |
Why?
|
| Behavioral Medicine | 1 | 2005 | 49 | 0.240 |
Why?
|
| Receptors, Estrogen | 3 | 2022 | 2208 | 0.240 |
Why?
|
| Receptors, Progesterone | 1 | 2009 | 1129 | 0.240 |
Why?
|
| Neoplasm Proteins | 4 | 2015 | 3607 | 0.240 |
Why?
|
| Neoplasm Staging | 12 | 2017 | 11118 | 0.240 |
Why?
|
| RNA, Messenger | 6 | 2016 | 12759 | 0.240 |
Why?
|
| Drug Carriers | 1 | 2009 | 706 | 0.230 |
Why?
|
| Selective Estrogen Receptor Modulators | 2 | 2004 | 131 | 0.230 |
Why?
|
| Spheniscidae | 1 | 2023 | 9 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2024 | 184 | 0.230 |
Why?
|
| Female | 100 | 2024 | 392203 | 0.230 |
Why?
|
| Hawaii | 4 | 2007 | 101 | 0.220 |
Why?
|
| Cyclic AMP Response Element-Binding Protein A | 2 | 2022 | 21 | 0.220 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 982 | 0.220 |
Why?
|
| Transcription, Genetic | 5 | 2024 | 7583 | 0.220 |
Why?
|
| Anticarcinogenic Agents | 2 | 2017 | 249 | 0.220 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2011 | 1520 | 0.220 |
Why?
|
| Guidelines as Topic | 5 | 2009 | 1386 | 0.220 |
Why?
|
| Allelic Imbalance | 2 | 2021 | 77 | 0.210 |
Why?
|
| Professional Competence | 1 | 2006 | 431 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2016 | 350 | 0.210 |
Why?
|
| Phenylthiohydantoin | 3 | 2019 | 205 | 0.210 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2022 | 125 | 0.210 |
Why?
|
| Alzheimer Disease | 8 | 1998 | 8603 | 0.200 |
Why?
|
| Genomics | 10 | 2024 | 5822 | 0.200 |
Why?
|
| Carcinoma, Ductal, Breast | 4 | 2022 | 1084 | 0.200 |
Why?
|
| Colonic Neoplasms | 2 | 2014 | 2533 | 0.200 |
Why?
|
| Oncogene Protein p55(v-myc) | 1 | 2021 | 5 | 0.200 |
Why?
|
| Task Performance and Analysis | 1 | 2006 | 763 | 0.200 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 3 | 1998 | 1068 | 0.200 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2015 | 1113 | 0.200 |
Why?
|
| Genome, Human | 9 | 2020 | 4421 | 0.200 |
Why?
|
| Nitriles | 4 | 2022 | 971 | 0.190 |
Why?
|
| Vitamin B 12 Deficiency | 2 | 2000 | 118 | 0.190 |
Why?
|
| Genes, BRCA1 | 1 | 2005 | 753 | 0.190 |
Why?
|
| Disease Progression | 12 | 2021 | 13495 | 0.190 |
Why?
|
| Prostate-Specific Antigen | 4 | 2023 | 2465 | 0.180 |
Why?
|
| Protein Binding | 5 | 2024 | 9345 | 0.180 |
Why?
|
| Nucleotides | 1 | 2023 | 453 | 0.180 |
Why?
|
| Exons | 3 | 2021 | 2381 | 0.180 |
Why?
|
| Colorectal Neoplasms | 4 | 2017 | 6927 | 0.180 |
Why?
|
| Odds Ratio | 10 | 2019 | 9644 | 0.180 |
Why?
|
| Lipogenesis | 1 | 2022 | 214 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2024 | 584 | 0.180 |
Why?
|
| Genetic Techniques | 2 | 2021 | 428 | 0.180 |
Why?
|
| Neuropsychological Tests | 5 | 2011 | 7050 | 0.180 |
Why?
|
| Mutation, Missense | 5 | 2009 | 2570 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2015 | 571 | 0.170 |
Why?
|
| Carcinoma, Lobular | 3 | 2022 | 480 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 3593 | 0.170 |
Why?
|
| SOXF Transcription Factors | 1 | 2019 | 31 | 0.170 |
Why?
|
| Observer Variation | 1 | 2006 | 2607 | 0.170 |
Why?
|
| Hematologic Diseases | 3 | 1999 | 496 | 0.170 |
Why?
|
| RNA Interference | 2 | 2021 | 2829 | 0.170 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 189 | 0.170 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2019 | 30 | 0.170 |
Why?
|
| Aged, 80 and over | 24 | 2021 | 58919 | 0.170 |
Why?
|
| Cognition Disorders | 3 | 2011 | 3979 | 0.170 |
Why?
|
| Chromosomes, Human | 1 | 2021 | 441 | 0.170 |
Why?
|
| Dementia | 5 | 2010 | 2686 | 0.170 |
Why?
|
| Prognosis | 15 | 2024 | 29601 | 0.170 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2019 | 32 | 0.160 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2001 | 276 | 0.160 |
Why?
|
| Phenylenediamines | 1 | 2019 | 88 | 0.160 |
Why?
|
| Transcription Factor AP-1 | 1 | 2020 | 319 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2022 | 5304 | 0.160 |
Why?
|
| Models, Genetic | 6 | 2019 | 3431 | 0.160 |
Why?
|
| Rhabdoid Tumor | 1 | 2021 | 210 | 0.160 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2017 | 852 | 0.160 |
Why?
|
| Acatalasia | 1 | 1998 | 1 | 0.160 |
Why?
|
| Benzamides | 3 | 2019 | 1371 | 0.150 |
Why?
|
| Selegiline | 1 | 1998 | 32 | 0.150 |
Why?
|
| Inheritance Patterns | 2 | 2020 | 341 | 0.150 |
Why?
|
| Neoplasm Metastasis | 3 | 2018 | 4910 | 0.150 |
Why?
|
| Personality | 1 | 2001 | 553 | 0.150 |
Why?
|
| Cell Proliferation | 5 | 2024 | 10429 | 0.150 |
Why?
|
| Benzofurans | 1 | 1998 | 139 | 0.150 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1998 | 155 | 0.150 |
Why?
|
| Disability Evaluation | 1 | 2005 | 1835 | 0.150 |
Why?
|
| Prostatectomy | 5 | 2021 | 1825 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1998 | 287 | 0.150 |
Why?
|
| Genetic Linkage | 3 | 2013 | 2340 | 0.150 |
Why?
|
| Adult | 44 | 2024 | 220995 | 0.140 |
Why?
|
| Histone Deacetylases | 1 | 2022 | 719 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 737 | 0.140 |
Why?
|
| Aspirin | 3 | 2017 | 3127 | 0.140 |
Why?
|
| Phenotype | 9 | 2023 | 16572 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 9 | 2011 | 6074 | 0.140 |
Why?
|
| Lipid Peroxidation | 1 | 1998 | 271 | 0.140 |
Why?
|
| Oncogenes | 1 | 2023 | 1220 | 0.140 |
Why?
|
| Neurology | 1 | 2005 | 784 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2021 | 3634 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 829 | 0.140 |
Why?
|
| Glutathione Peroxidase | 1 | 1998 | 258 | 0.140 |
Why?
|
| Penetrance | 3 | 2021 | 382 | 0.140 |
Why?
|
| Mammography | 6 | 2007 | 2430 | 0.140 |
Why?
|
| Psychomotor Performance | 2 | 1998 | 1882 | 0.140 |
Why?
|
| Pyrrolidines | 1 | 1998 | 338 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2015 | 6473 | 0.130 |
Why?
|
| Radiography, Interventional | 1 | 2004 | 1120 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 4408 | 0.130 |
Why?
|
| Genetic Testing | 3 | 2020 | 3533 | 0.130 |
Why?
|
| Mass Screening | 7 | 2008 | 5425 | 0.130 |
Why?
|
| Nuchal Cord | 1 | 2015 | 5 | 0.130 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 2 | 2006 | 56 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2000 | 489 | 0.130 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2011 | 550 | 0.130 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1998 | 484 | 0.130 |
Why?
|
| Predictive Value of Tests | 9 | 2024 | 15250 | 0.130 |
Why?
|
| National Cancer Institute (U.S.) | 3 | 2015 | 296 | 0.130 |
Why?
|
| Cognition | 4 | 2022 | 6988 | 0.130 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 305 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2006 | 3356 | 0.130 |
Why?
|
| Prospective Studies | 17 | 2024 | 54364 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 1614 | 0.130 |
Why?
|
| Radiography, Thoracic | 4 | 2006 | 1302 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 4 | 2021 | 4739 | 0.120 |
Why?
|
| Superoxide Dismutase | 1 | 1998 | 593 | 0.120 |
Why?
|
| Anemia, Macrocytic | 2 | 2013 | 53 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2010 | 3481 | 0.120 |
Why?
|
| Membrane Proteins | 4 | 2016 | 7847 | 0.120 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2018 | 651 | 0.120 |
Why?
|
| Behavior | 1 | 1998 | 540 | 0.120 |
Why?
|
| Binding Sites | 4 | 2020 | 6051 | 0.120 |
Why?
|
| DNA Damage | 3 | 2021 | 2445 | 0.120 |
Why?
|
| Iodine Radioisotopes | 1 | 1998 | 1031 | 0.120 |
Why?
|
| Telomere | 2 | 2017 | 942 | 0.120 |
Why?
|
| Visual Perception | 2 | 2006 | 1388 | 0.120 |
Why?
|
| Gene Frequency | 5 | 2009 | 3601 | 0.120 |
Why?
|
| Immunoblotting | 2 | 2015 | 1646 | 0.120 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2021 | 782 | 0.120 |
Why?
|
| Computational Biology | 4 | 2019 | 3509 | 0.120 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 422 | 0.110 |
Why?
|
| Organotechnetium Compounds | 1 | 1994 | 129 | 0.110 |
Why?
|
| Neutropenia | 5 | 2001 | 885 | 0.110 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2015 | 263 | 0.110 |
Why?
|
| Blood Proteins | 3 | 2016 | 1172 | 0.110 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 1745 | 0.110 |
Why?
|
| Taxoids | 1 | 2017 | 667 | 0.110 |
Why?
|
| Endometriosis | 1 | 2022 | 857 | 0.110 |
Why?
|
| Disease | 2 | 2009 | 670 | 0.110 |
Why?
|
| Receptors, Transferrin | 2 | 2013 | 291 | 0.110 |
Why?
|
| Sensitivity and Specificity | 9 | 2011 | 14649 | 0.110 |
Why?
|
| Genes | 2 | 2013 | 1823 | 0.110 |
Why?
|
| Publishing | 3 | 2009 | 832 | 0.110 |
Why?
|
| Sorting Nexins | 1 | 2013 | 27 | 0.110 |
Why?
|
| Organ Specificity | 3 | 2016 | 1964 | 0.110 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2013 | 152 | 0.110 |
Why?
|
| DNA Primers | 5 | 2009 | 2817 | 0.100 |
Why?
|
| Isoleucine | 4 | 2007 | 110 | 0.100 |
Why?
|
| Loss of Heterozygosity | 2 | 2006 | 662 | 0.100 |
Why?
|
| Oximes | 1 | 1994 | 303 | 0.100 |
Why?
|
| Survival Rate | 6 | 2020 | 12719 | 0.100 |
Why?
|
| Cell Line | 4 | 2020 | 15577 | 0.100 |
Why?
|
| Corpus Striatum | 1 | 1998 | 1235 | 0.100 |
Why?
|
| Estradiol Dehydrogenases | 1 | 2011 | 16 | 0.100 |
Why?
|
| Research Design | 5 | 2017 | 6174 | 0.100 |
Why?
|
| Animals | 31 | 2024 | 168202 | 0.100 |
Why?
|
| Threonine | 4 | 2007 | 271 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2015 | 2703 | 0.100 |
Why?
|
| Olivopontocerebellar Atrophies | 1 | 1991 | 19 | 0.100 |
Why?
|
| DNA-Binding Proteins | 5 | 2020 | 9586 | 0.100 |
Why?
|
| Genes, Neoplasm | 2 | 2021 | 370 | 0.100 |
Why?
|
| Risk Assessment | 8 | 2017 | 23974 | 0.100 |
Why?
|
| Reticulocytes | 6 | 1983 | 289 | 0.100 |
Why?
|
| Regional Blood Flow | 2 | 1996 | 1496 | 0.100 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2011 | 28 | 0.100 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 6807 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2019 | 3599 | 0.090 |
Why?
|
| Catechols | 1 | 2011 | 62 | 0.090 |
Why?
|
| Hemoglobins | 7 | 2005 | 1524 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2006 | 310 | 0.090 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2011 | 121 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4269 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2009 | 386 | 0.090 |
Why?
|
| Apolipoprotein E3 | 1 | 2011 | 107 | 0.090 |
Why?
|
| Aging | 4 | 2005 | 8700 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2022 | 9277 | 0.090 |
Why?
|
| Organic Anion Transporters | 1 | 2011 | 101 | 0.090 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2011 | 158 | 0.090 |
Why?
|
| United States | 16 | 2015 | 72292 | 0.090 |
Why?
|
| Mental Status Schedule | 1 | 2011 | 315 | 0.090 |
Why?
|
| Reflex, Abnormal | 1 | 2010 | 83 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2011 | 36401 | 0.090 |
Why?
|
| Antioxidants | 1 | 1998 | 1669 | 0.090 |
Why?
|
| Response Elements | 1 | 2011 | 309 | 0.080 |
Why?
|
| Dominance, Cerebral | 1 | 1991 | 623 | 0.080 |
Why?
|
| Mitochondrial Diseases | 1 | 2013 | 343 | 0.080 |
Why?
|
| Survival Analysis | 3 | 2021 | 10072 | 0.080 |
Why?
|
| Mental Recall | 2 | 1998 | 1222 | 0.080 |
Why?
|
| Lymphocytes | 4 | 1994 | 2604 | 0.080 |
Why?
|
| Emotions | 1 | 2001 | 2741 | 0.080 |
Why?
|
| Base Sequence | 10 | 2019 | 12420 | 0.080 |
Why?
|
| Sequence Analysis | 2 | 2022 | 240 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2013 | 733 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2006 | 2925 | 0.080 |
Why?
|
| Trinucleotide Repeats | 1 | 2010 | 257 | 0.080 |
Why?
|
| Gene Dosage | 2 | 2010 | 1217 | 0.080 |
Why?
|
| Tamoxifen | 2 | 2022 | 965 | 0.080 |
Why?
|
| Orchiectomy | 1 | 2011 | 463 | 0.080 |
Why?
|
| TCF Transcription Factors | 1 | 2009 | 138 | 0.080 |
Why?
|
| Anemia | 4 | 2013 | 1504 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 1998 | 2650 | 0.080 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2021 | 2223 | 0.080 |
Why?
|
| Genes, Dominant | 1 | 1991 | 851 | 0.080 |
Why?
|
| beta Catenin | 1 | 2013 | 1039 | 0.080 |
Why?
|
| Epithelium | 1 | 2013 | 1603 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4569 | 0.080 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 602 | 0.080 |
Why?
|
| Cell Survival | 1 | 2018 | 5780 | 0.080 |
Why?
|
| Mice | 14 | 2024 | 81368 | 0.080 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2010 | 240 | 0.080 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 3 | 2001 | 629 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 516 | 0.070 |
Why?
|
| Algorithms | 5 | 2020 | 14024 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 2 | 1996 | 2726 | 0.070 |
Why?
|
| Molecular Epidemiology | 1 | 2009 | 470 | 0.070 |
Why?
|
| Parkinsonian Disorders | 1 | 2010 | 285 | 0.070 |
Why?
|
| GTPase-Activating Proteins | 1 | 2010 | 471 | 0.070 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2008 | 186 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1639 | 0.070 |
Why?
|
| Logistic Models | 4 | 2013 | 13248 | 0.070 |
Why?
|
| Chromosomes, Human, X | 1 | 2009 | 321 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2019 | 3027 | 0.070 |
Why?
|
| Histidine | 1 | 2007 | 308 | 0.070 |
Why?
|
| Sequence Tagged Sites | 1 | 2006 | 96 | 0.070 |
Why?
|
| Mass Chest X-Ray | 1 | 2006 | 18 | 0.070 |
Why?
|
| RNA, Neoplasm | 2 | 2009 | 749 | 0.070 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2016 | 1073 | 0.070 |
Why?
|
| Ibuprofen | 1 | 1988 | 229 | 0.070 |
Why?
|
| Gene Knockout Techniques | 2 | 2020 | 802 | 0.070 |
Why?
|
| Leucine | 2 | 2007 | 548 | 0.070 |
Why?
|
| Tomography, Spiral Computed | 2 | 2005 | 273 | 0.070 |
Why?
|
| Epidemiology | 1 | 2009 | 279 | 0.070 |
Why?
|
| Reproducibility of Results | 7 | 2015 | 20077 | 0.070 |
Why?
|
| Adipocytes | 1 | 2013 | 1187 | 0.070 |
Why?
|
| Adenoma | 1 | 2017 | 2159 | 0.070 |
Why?
|
| Azepines | 2 | 2018 | 329 | 0.070 |
Why?
|
| Jehovah's Witnesses | 1 | 2005 | 13 | 0.070 |
Why?
|
| Proline | 1 | 2007 | 455 | 0.070 |
Why?
|
| DNA Mutational Analysis | 3 | 2011 | 4110 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2014 | 3802 | 0.060 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2010 | 604 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 208 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2022 | 1133 | 0.060 |
Why?
|
| Iron | 4 | 2013 | 1790 | 0.060 |
Why?
|
| Los Angeles | 1 | 2006 | 244 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 1 | 2011 | 1077 | 0.060 |
Why?
|
| Blood Substitutes | 1 | 2005 | 57 | 0.060 |
Why?
|
| Glucose | 1 | 1997 | 4345 | 0.060 |
Why?
|
| Ovary | 2 | 2020 | 959 | 0.060 |
Why?
|
| DNA | 5 | 2020 | 7196 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2005 | 78 | 0.060 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2011 | 1148 | 0.060 |
Why?
|
| Signal Transduction | 9 | 2022 | 23415 | 0.060 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2011 | 614 | 0.060 |
Why?
|
| Reaction Time | 1 | 1991 | 2087 | 0.060 |
Why?
|
| Nucleosomes | 2 | 2023 | 487 | 0.060 |
Why?
|
| Molecular Sequence Annotation | 2 | 2018 | 520 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 11874 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2007 | 1989 | 0.060 |
Why?
|
| Nephrectomy | 2 | 2024 | 937 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2019 | 3672 | 0.060 |
Why?
|
| Melanoma | 1 | 2022 | 5696 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2011 | 1799 | 0.060 |
Why?
|
| Joint Diseases | 1 | 1988 | 459 | 0.060 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2024 | 101 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 1335 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3088 | 0.060 |
Why?
|
| Introns | 1 | 2006 | 968 | 0.060 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 2 | 1993 | 38 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2024 | 1894 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 2896 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 3 | 2017 | 1380 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2021 | 455 | 0.050 |
Why?
|
| Cell Cycle Proteins | 3 | 2024 | 3447 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 1827 | 0.050 |
Why?
|
| Thorax | 1 | 2006 | 555 | 0.050 |
Why?
|
| Tyrosine | 1 | 2007 | 1440 | 0.050 |
Why?
|
| Mammaplasty | 1 | 2013 | 1232 | 0.050 |
Why?
|
| Neurons | 2 | 2022 | 9436 | 0.050 |
Why?
|
| Obesity | 3 | 2019 | 12934 | 0.050 |
Why?
|
| Chromosome Inversion | 2 | 1993 | 120 | 0.050 |
Why?
|
| Age of Onset | 2 | 2007 | 3303 | 0.050 |
Why?
|
| Blood Transfusion | 3 | 2005 | 1300 | 0.050 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2003 | 99 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2005 | 506 | 0.050 |
Why?
|
| Triazoles | 2 | 2018 | 903 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2005 | 693 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2019 | 1007 | 0.050 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2024 | 304 | 0.050 |
Why?
|
| California | 1 | 2006 | 1431 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 783 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2010 | 2916 | 0.050 |
Why?
|
| Blood Cell Count | 3 | 1983 | 397 | 0.050 |
Why?
|
| Radiographic Image Enhancement | 2 | 2004 | 876 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3776 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 96 | 0.050 |
Why?
|
| Young Adult | 7 | 2021 | 59191 | 0.050 |
Why?
|
| Nuclear Proteins | 4 | 2020 | 5789 | 0.050 |
Why?
|
| Heterozygote | 3 | 2019 | 2780 | 0.050 |
Why?
|
| Neurologic Examination | 1 | 2005 | 915 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 1993 | 343 | 0.050 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 12043 | 0.050 |
Why?
|
| Models, Biological | 7 | 2011 | 9461 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 2 | 2000 | 2690 | 0.050 |
Why?
|
| Research | 2 | 2009 | 1977 | 0.050 |
Why?
|
| Genealogy and Heraldry | 1 | 2021 | 29 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2013 | 6223 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2005 | 709 | 0.050 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2022 | 129 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2005 | 2358 | 0.050 |
Why?
|
| Body Mass Index | 4 | 2019 | 12942 | 0.050 |
Why?
|
| Thrombospondins | 1 | 2001 | 193 | 0.050 |
Why?
|
| Testosterone | 3 | 2022 | 2472 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2022 | 286 | 0.050 |
Why?
|
| Cerebellum | 2 | 1998 | 1501 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2019 | 8311 | 0.050 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2001 | 53 | 0.050 |
Why?
|
| Attention | 1 | 1991 | 2396 | 0.050 |
Why?
|
| Apolipoproteins E | 2 | 1998 | 1443 | 0.040 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 13635 | 0.040 |
Why?
|
| Methylmalonic Acid | 1 | 2000 | 49 | 0.040 |
Why?
|
| Genes, cdc | 1 | 2020 | 114 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2011 | 20556 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2017 | 12333 | 0.040 |
Why?
|
| Brain | 4 | 2005 | 27100 | 0.040 |
Why?
|
| Proteins | 3 | 2023 | 6030 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2022 | 2985 | 0.040 |
Why?
|
| Apoptosis | 4 | 1998 | 9476 | 0.040 |
Why?
|
| T-Lymphocytes | 5 | 2000 | 10175 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2024 | 2851 | 0.040 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2024 | 423 | 0.040 |
Why?
|
| Computer Simulation | 5 | 2020 | 6233 | 0.040 |
Why?
|
| Postmenopause | 2 | 2008 | 2511 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 294 | 0.040 |
Why?
|
| Patient Selection | 2 | 2004 | 4237 | 0.040 |
Why?
|
| Kidney | 2 | 2021 | 7044 | 0.040 |
Why?
|
| Ribosomes | 4 | 1976 | 500 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 1970 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2004 | 709 | 0.040 |
Why?
|
| Fallopian Tubes | 1 | 2019 | 178 | 0.040 |
Why?
|
| Thalassemia | 2 | 1983 | 260 | 0.040 |
Why?
|
| Pedigree | 3 | 2017 | 4539 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2022 | 80583 | 0.040 |
Why?
|
| Heme | 3 | 1976 | 313 | 0.040 |
Why?
|
| Benzene | 2 | 1976 | 106 | 0.040 |
Why?
|
| Adolescent | 13 | 2021 | 88247 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2009 | 6126 | 0.040 |
Why?
|
| ROC Curve | 2 | 2024 | 3575 | 0.040 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1998 | 45 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11735 | 0.040 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 1999 | 86 | 0.040 |
Why?
|
| Prevalence | 6 | 2010 | 15702 | 0.040 |
Why?
|
| Genes, Immediate-Early | 1 | 1998 | 102 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4570 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 237 | 0.040 |
Why?
|
| Affective Symptoms | 1 | 2001 | 417 | 0.040 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2019 | 150 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2011 | 4745 | 0.040 |
Why?
|
| Streptococcus mutans | 1 | 1978 | 99 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 1265 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2009 | 1463 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 697 | 0.040 |
Why?
|
| Age Factors | 4 | 2017 | 18381 | 0.040 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2000 | 266 | 0.040 |
Why?
|
| Massachusetts | 1 | 2010 | 8835 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2004 | 1110 | 0.040 |
Why?
|
| Psychosurgery | 1 | 1998 | 86 | 0.040 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2000 | 227 | 0.040 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2001 | 396 | 0.040 |
Why?
|
| Cloning, Molecular | 4 | 1995 | 4172 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 1998 | 613 | 0.040 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 1997 | 21 | 0.040 |
Why?
|
| Heredity | 1 | 2017 | 148 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 702 | 0.040 |
Why?
|
| Hexokinase | 1 | 1997 | 124 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 504 | 0.040 |
Why?
|
| Thrombocytosis | 1 | 1977 | 88 | 0.040 |
Why?
|
| Homocysteine | 1 | 2000 | 637 | 0.040 |
Why?
|
| Anemia, Sickle Cell | 2 | 1976 | 1061 | 0.040 |
Why?
|
| Health Behavior | 1 | 2008 | 2643 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 1608 | 0.030 |
Why?
|
| Spinal Cord Diseases | 1 | 2000 | 291 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2004 | 1222 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 1997 | 333 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2020 | 561 | 0.030 |
Why?
|
| Peptide Biosynthesis | 3 | 1971 | 52 | 0.030 |
Why?
|
| Plasma | 1 | 2020 | 586 | 0.030 |
Why?
|
| Polycythemia | 1 | 1997 | 124 | 0.030 |
Why?
|
| Radiography | 2 | 2005 | 6961 | 0.030 |
Why?
|
| Immunity | 1 | 2022 | 994 | 0.030 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1996 | 67 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2019 | 813 | 0.030 |
Why?
|
| Molecular Sequence Data | 8 | 1996 | 17630 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2006 | 1909 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 2001 | 891 | 0.030 |
Why?
|
| Monosomy | 1 | 1995 | 52 | 0.030 |
Why?
|
| Aggression | 1 | 2001 | 750 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2006 | 2597 | 0.030 |
Why?
|
| Contrast Media | 1 | 2009 | 5305 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1996 | 2546 | 0.030 |
Why?
|
| Prostaglandins | 1 | 2017 | 398 | 0.030 |
Why?
|
| Blood Platelets | 2 | 1977 | 2478 | 0.030 |
Why?
|
| Community Networks | 1 | 1997 | 201 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 2 | 2020 | 2689 | 0.030 |
Why?
|
| Gamma Rays | 2 | 1994 | 318 | 0.030 |
Why?
|
| Zebrafish | 3 | 2013 | 3005 | 0.030 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2017 | 284 | 0.030 |
Why?
|
| Genetic Vectors | 3 | 1994 | 3392 | 0.030 |
Why?
|
| Health Services for the Aged | 1 | 1997 | 258 | 0.030 |
Why?
|
| Family | 3 | 2016 | 3193 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 15829 | 0.030 |
Why?
|
| Spinal Diseases | 1 | 2000 | 561 | 0.030 |
Why?
|
| Incidence | 4 | 2009 | 21339 | 0.030 |
Why?
|
| Forecasting | 1 | 2004 | 2924 | 0.030 |
Why?
|
| Atlases as Topic | 1 | 2016 | 247 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2020 | 851 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2020 | 1152 | 0.030 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 1994 | 61 | 0.030 |
Why?
|
| Apolipoproteins C | 1 | 1994 | 59 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 1 | 1997 | 1122 | 0.030 |
Why?
|
| Orbit | 1 | 1998 | 457 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 2222 | 0.030 |
Why?
|
| Cell Count | 1 | 1998 | 1834 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1998 | 960 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2015 | 265 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2001 | 1208 | 0.030 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 1994 | 74 | 0.030 |
Why?
|
| Hominidae | 1 | 1994 | 67 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2015 | 469 | 0.030 |
Why?
|
| Iron Overload | 1 | 1996 | 239 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2019 | 1088 | 0.030 |
Why?
|
| Epinephrine | 1 | 1977 | 792 | 0.030 |
Why?
|
| Multiple Sclerosis | 2 | 2001 | 3222 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 4010 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2017 | 748 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2022 | 1896 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2625 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2022 | 2020 | 0.030 |
Why?
|
| Dental Caries | 1 | 1978 | 427 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2022 | 4117 | 0.030 |
Why?
|
| Energy Intake | 1 | 2001 | 2133 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2022 | 2894 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 22117 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2001 | 1995 | 0.030 |
Why?
|
| DNA Replication | 2 | 2007 | 1414 | 0.030 |
Why?
|
| Follow-Up Studies | 6 | 2021 | 39062 | 0.030 |
Why?
|
| Genes, ras | 1 | 1995 | 654 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 1754 | 0.030 |
Why?
|
| Cell Differentiation | 3 | 2024 | 11512 | 0.030 |
Why?
|
| Wnt Proteins | 2 | 2013 | 718 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2013 | 222 | 0.030 |
Why?
|
| Neutrophils | 3 | 2001 | 3763 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2019 | 18937 | 0.030 |
Why?
|
| Microcirculation | 1 | 1997 | 1272 | 0.030 |
Why?
|
| Growth Substances | 1 | 1995 | 768 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2013 | 4845 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2019 | 1742 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2020 | 2764 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1994 | 880 | 0.020 |
Why?
|
| Myosins | 1 | 1993 | 404 | 0.020 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 1996 | 369 | 0.020 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2011 | 25 | 0.020 |
Why?
|
| Presenilin-1 | 1 | 1995 | 660 | 0.020 |
Why?
|
| Plasmids | 2 | 1994 | 2265 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 783 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2001 | 2419 | 0.020 |
Why?
|
| Point Mutation | 1 | 1997 | 1595 | 0.020 |
Why?
|
| Ataxia Telangiectasia | 1 | 1992 | 107 | 0.020 |
Why?
|
| Diagnosis, Differential | 6 | 1998 | 12966 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1436 | 0.020 |
Why?
|
| Child, Preschool | 8 | 2021 | 42193 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 2569 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1525 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2001 | 1405 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 2456 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2803 | 0.020 |
Why?
|
| Mitochondria | 1 | 2004 | 3619 | 0.020 |
Why?
|
| Life Expectancy | 1 | 1997 | 1242 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 3451 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 1125 | 0.020 |
Why?
|
| Positron-Emission Tomography | 2 | 2023 | 6483 | 0.020 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2011 | 241 | 0.020 |
Why?
|
| Early Diagnosis | 2 | 2006 | 1185 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2011 | 315 | 0.020 |
Why?
|
| Sex Factors | 2 | 2019 | 10549 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 1998 | 1695 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2011 | 254 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2018 | 2327 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2009 | 5074 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3868 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2017 | 64572 | 0.020 |
Why?
|
| Morbidity | 1 | 2015 | 1750 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2827 | 0.020 |
Why?
|
| Kinetics | 1 | 1997 | 6370 | 0.020 |
Why?
|
| Cross-Sectional Studies | 4 | 2008 | 26065 | 0.020 |
Why?
|
| Erythropoiesis | 1 | 2013 | 684 | 0.020 |
Why?
|
| Genetic Phenomena | 1 | 2009 | 6 | 0.020 |
Why?
|
| Time Factors | 5 | 2017 | 39908 | 0.020 |
Why?
|
| Leukocytes | 1 | 2017 | 2024 | 0.020 |
Why?
|
| Nuclear Family | 2 | 2001 | 311 | 0.020 |
Why?
|
| Stem Cells | 1 | 2022 | 3514 | 0.020 |
Why?
|
| Antigens | 1 | 1995 | 1441 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 3196 | 0.020 |
Why?
|
| Hematocrit | 2 | 1997 | 623 | 0.020 |
Why?
|
| Rabbits | 6 | 1977 | 4770 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2001 | 3183 | 0.020 |
Why?
|
| Likelihood Functions | 2 | 2003 | 991 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2467 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2004 | 7963 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 1998 | 1999 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2011 | 4512 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2447 | 0.020 |
Why?
|
| Lymphocyte Count | 2 | 2001 | 777 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 367 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1884 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 5369 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2015 | 2659 | 0.020 |
Why?
|
| Child | 9 | 2021 | 80089 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2001 | 313 | 0.020 |
Why?
|
| Hodgkin Disease | 2 | 1990 | 1378 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1998 | 6016 | 0.020 |
Why?
|
| Lipids | 1 | 2019 | 3332 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 974 | 0.020 |
Why?
|
| Erythropoietin | 2 | 2005 | 719 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2011 | 793 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2011 | 665 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1992 | 1386 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2015 | 1608 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 789 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 2006 | 4309 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 1998 | 3115 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 2089 | 0.020 |
Why?
|
| Cough | 1 | 1990 | 595 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 1995 | 1589 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1503 | 0.020 |
Why?
|
| Microscopy, Scanning Probe | 1 | 2006 | 6 | 0.020 |
Why?
|
| Biopsy | 3 | 2005 | 6763 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2006 | 200 | 0.020 |
Why?
|
| Hemosiderin | 1 | 2005 | 41 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 18220 | 0.020 |
Why?
|
| Cytokines | 2 | 2017 | 7373 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 1988 | 677 | 0.020 |
Why?
|
| Hippocampus | 1 | 1998 | 3762 | 0.020 |
Why?
|
| Nigeria | 1 | 2008 | 772 | 0.020 |
Why?
|
| Psychotic Disorders | 1 | 2001 | 3220 | 0.020 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1995 | 1394 | 0.020 |
Why?
|
| Cyclin B | 1 | 2005 | 104 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2000 | 3527 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 5034 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 2001 | 6520 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2000 | 8998 | 0.020 |
Why?
|
| Diuretics | 1 | 1988 | 611 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 1994 | 2298 | 0.010 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2004 | 67 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2019 | 6390 | 0.010 |
Why?
|
| Insulin | 1 | 2019 | 6593 | 0.010 |
Why?
|
| K562 Cells | 1 | 2006 | 641 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9313 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 944 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2006 | 280 | 0.010 |
Why?
|
| Feasibility Studies | 2 | 2005 | 5239 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2270 | 0.010 |
Why?
|
| Homozygote | 2 | 2001 | 1776 | 0.010 |
Why?
|
| Random Allocation | 1 | 1988 | 2392 | 0.010 |
Why?
|
| Chlorambucil | 1 | 1983 | 42 | 0.010 |
Why?
|
| Pilot Projects | 3 | 2004 | 8619 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 1997 | 3611 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2018 | 14388 | 0.010 |
Why?
|
| Syndrome | 2 | 2000 | 3268 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2019 | 8473 | 0.010 |
Why?
|
| Infant | 6 | 2001 | 36157 | 0.010 |
Why?
|
| Diet | 1 | 2001 | 8049 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2004 | 573 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1983 | 310 | 0.010 |
Why?
|
| Restriction Mapping | 2 | 1993 | 851 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 2004 | 289 | 0.010 |
Why?
|
| Mammary Glands, Human | 1 | 2004 | 202 | 0.010 |
Why?
|
| Chemoprevention | 1 | 2004 | 325 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2009 | 1606 | 0.010 |
Why?
|
| Erythrocyte Indices | 1 | 1983 | 144 | 0.010 |
Why?
|
| Clone Cells | 2 | 1996 | 1657 | 0.010 |
Why?
|
| Globins | 3 | 1974 | 405 | 0.010 |
Why?
|
| Nipples | 1 | 2004 | 229 | 0.010 |
Why?
|
| Emigrants and Immigrants | 1 | 2008 | 544 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2005 | 905 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2001 | 6403 | 0.010 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2001 | 61 | 0.010 |
Why?
|
| Liposomes | 1 | 2006 | 784 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2000 | 5671 | 0.010 |
Why?
|
| Polycythemia Vera | 1 | 1983 | 161 | 0.010 |
Why?
|
| Bacterial Infections | 2 | 2000 | 1389 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1835 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2005 | 2214 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2001 | 11458 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15498 | 0.010 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2001 | 276 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1991 | 3056 | 0.010 |
Why?
|
| Platelet Count | 1 | 1983 | 780 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3419 | 0.010 |
Why?
|
| Mitosis | 1 | 2005 | 1187 | 0.010 |
Why?
|
| Splenomegaly | 1 | 2001 | 190 | 0.010 |
Why?
|
| Nanotechnology | 1 | 2006 | 713 | 0.010 |
Why?
|
| Thrombospondin 1 | 1 | 2001 | 257 | 0.010 |
Why?
|
| Vitamin B 12 | 1 | 1983 | 524 | 0.010 |
Why?
|
| Congresses as Topic | 1 | 2005 | 802 | 0.010 |
Why?
|
| Ontario | 1 | 2001 | 397 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 3841 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 476 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2000 | 507 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 2001 | 601 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1999 | 84 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 2001 | 641 | 0.010 |
Why?
|
| Trypsinogen | 1 | 1999 | 84 | 0.010 |
Why?
|
| Diet, Vegetarian | 1 | 2001 | 180 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2006 | 3606 | 0.010 |
Why?
|
| Hemin | 2 | 1976 | 51 | 0.010 |
Why?
|
| Polysaccharides, Bacterial | 2 | 1983 | 578 | 0.010 |
Why?
|
| Data Display | 1 | 2000 | 175 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2001 | 361 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1971 | 458 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2005 | 1866 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 1972 | 0.010 |
Why?
|
| Schizophrenia | 1 | 1998 | 6929 | 0.010 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2004 | 1118 | 0.010 |
Why?
|
| Delusions | 1 | 2001 | 298 | 0.010 |
Why?
|
| Dextranase | 1 | 1978 | 2 | 0.010 |
Why?
|
| Bone Diseases, Developmental | 1 | 1999 | 131 | 0.010 |
Why?
|
| Polymers | 1 | 2005 | 1614 | 0.010 |
Why?
|
| Adhesiveness | 1 | 1978 | 52 | 0.010 |
Why?
|
| Computer Systems | 1 | 2000 | 469 | 0.010 |
Why?
|
| Hallucinations | 1 | 2001 | 366 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 1999 | 310 | 0.010 |
Why?
|
| Pneumococcal Infections | 1 | 1983 | 501 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 12448 | 0.010 |
Why?
|
| Health | 1 | 2001 | 398 | 0.010 |
Why?
|
| Glucans | 1 | 1978 | 68 | 0.010 |
Why?
|
| Systems Integration | 1 | 2000 | 426 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 2005 | 6305 | 0.010 |
Why?
|
| Diet, Reducing | 1 | 2001 | 485 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 1995 | 7995 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 2000 | 298 | 0.010 |
Why?
|
| Diet Surveys | 1 | 2001 | 1161 | 0.010 |
Why?
|
| Demography | 1 | 2001 | 1643 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 3680 | 0.010 |
Why?
|
| Ultraviolet Rays | 3 | 1971 | 1079 | 0.010 |
Why?
|
| Public Health | 1 | 2009 | 2671 | 0.010 |
Why?
|
| Gasoline | 1 | 1976 | 53 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1977 | 277 | 0.010 |
Why?
|
| Triage | 1 | 2003 | 984 | 0.010 |
Why?
|
| Fever | 2 | 2000 | 1618 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 2000 | 683 | 0.010 |
Why?
|
| Petroleum | 1 | 1976 | 80 | 0.010 |
Why?
|
| Myeloid Cells | 1 | 2001 | 823 | 0.010 |
Why?
|
| Splenectomy | 1 | 1977 | 389 | 0.010 |
Why?
|
| Procarbazine | 2 | 1990 | 172 | 0.010 |
Why?
|
| Mechlorethamine | 2 | 1990 | 129 | 0.010 |
Why?
|
| Canada | 1 | 2001 | 2120 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1995 | 329 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2001 | 794 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2005 | 2909 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1996 | 322 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2000 | 1390 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1996 | 410 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1977 | 1376 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2001 | 1392 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 2000 | 26183 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1996 | 817 | 0.010 |
Why?
|
| Apolipoprotein C-II | 1 | 1994 | 15 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7805 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 12143 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1977 | 668 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 2 | 2005 | 7403 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1999 | 634 | 0.010 |
Why?
|
| TATA Box | 1 | 1994 | 127 | 0.010 |
Why?
|
| Depression, Chemical | 2 | 1971 | 184 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1974 | 102 | 0.010 |
Why?
|
| Women's Health | 1 | 2004 | 2066 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 2000 | 905 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1993 | 113 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 1550 | 0.010 |
Why?
|
| Cosmids | 1 | 1993 | 105 | 0.010 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 1993 | 42 | 0.010 |
Why?
|
| Core Binding Factors | 1 | 1993 | 29 | 0.010 |
Why?
|
| Spectrophotometry | 2 | 1971 | 309 | 0.010 |
Why?
|
| Superantigens | 1 | 1994 | 126 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1974 | 225 | 0.010 |
Why?
|
| Interprofessional Relations | 1 | 2000 | 991 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 2851 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1996 | 870 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10754 | 0.010 |
Why?
|
| Transcription Factor AP-2 | 1 | 1993 | 78 | 0.010 |
Why?
|
| Chromosomes, Fungal | 1 | 1993 | 111 | 0.010 |
Why?
|
| Transplantation, Homologous | 2 | 1999 | 4802 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2000 | 1397 | 0.010 |
Why?
|
| Glutathione | 1 | 1976 | 582 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 2409 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1994 | 1058 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1996 | 13442 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1978 | 2495 | 0.010 |
Why?
|
| Vincristine | 2 | 1990 | 1036 | 0.010 |
Why?
|
| Robotics | 1 | 2000 | 817 | 0.010 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 1993 | 158 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 9526 | 0.010 |
Why?
|
| Age Distribution | 1 | 1998 | 2872 | 0.010 |
Why?
|
| X Chromosome | 1 | 1996 | 816 | 0.010 |
Why?
|
| Jews | 1 | 1994 | 356 | 0.010 |
Why?
|
| Dogs | 1 | 1977 | 3837 | 0.010 |
Why?
|
| Bilirubin | 1 | 1974 | 435 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2000 | 1009 | 0.010 |
Why?
|
| Hemolysis | 1 | 1974 | 415 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 704 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2000 | 1797 | 0.010 |
Why?
|
| Puromycin | 1 | 1971 | 42 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1971 | 299 | 0.010 |
Why?
|
| Celiac Disease | 1 | 1999 | 819 | 0.010 |
Why?
|
| Feedback | 1 | 1995 | 790 | 0.010 |
Why?
|
| Genetic Code | 1 | 1971 | 137 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1162 | 0.010 |
Why?
|
| Antimetabolites | 1 | 1971 | 129 | 0.010 |
Why?
|
| Prednisone | 2 | 1990 | 1562 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2000 | 2329 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1974 | 1597 | 0.010 |
Why?
|
| Lead | 1 | 1976 | 879 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2001 | 4470 | 0.010 |
Why?
|
| Endoscopy | 1 | 2000 | 1851 | 0.010 |
Why?
|
| Smoking | 1 | 2006 | 9054 | 0.010 |
Why?
|
| Weight Loss | 1 | 2001 | 2682 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1976 | 1988 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1993 | 1900 | 0.010 |
Why?
|
| Valine | 1 | 1971 | 408 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1993 | 927 | 0.010 |
Why?
|
| Spleen | 1 | 1975 | 2286 | 0.010 |
Why?
|
| Graft Survival | 1 | 2000 | 3814 | 0.010 |
Why?
|
| Neurofibromatosis 1 | 1 | 1994 | 560 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1971 | 611 | 0.000 |
Why?
|
| Sepsis | 1 | 1983 | 2585 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1976 | 2100 | 0.000 |
Why?
|
| Radiotherapy Dosage | 2 | 1990 | 2897 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1971 | 1433 | 0.000 |
Why?
|
| Survivors | 1 | 1999 | 2373 | 0.000 |
Why?
|
| Methylation | 1 | 1971 | 1077 | 0.000 |
Why?
|
| Protein Multimerization | 1 | 1993 | 982 | 0.000 |
Why?
|
| Peptide Hydrolases | 1 | 1971 | 624 | 0.000 |
Why?
|
| Trypsin | 1 | 1968 | 495 | 0.000 |
Why?
|
| Autoradiography | 1 | 1968 | 728 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 7390 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 3730 | 0.000 |
Why?
|
| Molecular Biology | 1 | 1971 | 575 | 0.000 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1993 | 2509 | 0.000 |
Why?
|
| Graft vs Host Disease | 1 | 2000 | 3026 | 0.000 |
Why?
|
| Software | 1 | 2001 | 4432 | 0.000 |
Why?
|
| Spectrum Analysis | 1 | 1968 | 452 | 0.000 |
Why?
|
| Spinal Cord | 1 | 1994 | 1807 | 0.000 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1990 | 592 | 0.000 |
Why?
|
| Communication | 1 | 2000 | 3851 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1994 | 2929 | 0.000 |
Why?
|
| Health Promotion | 1 | 1997 | 2206 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 5463 | 0.000 |
Why?
|
| Multiple Myeloma | 1 | 1983 | 5144 | 0.000 |
Why?
|
| Arginine | 1 | 1968 | 933 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1974 | 2410 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1977 | 2474 | 0.000 |
Why?
|
| Lysine | 1 | 1968 | 993 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11069 | 0.000 |
Why?
|
| Virus Diseases | 1 | 1990 | 718 | 0.000 |
Why?
|
| Recurrence | 2 | 1990 | 8426 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1993 | 2674 | 0.000 |
Why?
|
| Radiation Injuries | 1 | 1990 | 1189 | 0.000 |
Why?
|
| Rats | 1 | 1978 | 23716 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1979 | 384 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1990 | 8516 | 0.000 |
Why?
|
| Poly C | 1 | 1977 | 6 | 0.000 |
Why?
|
| Streptococcus pneumoniae | 1 | 1983 | 730 | 0.000 |
Why?
|
| Seasons | 1 | 1983 | 1518 | 0.000 |
Why?
|
| Polyribosomes | 1 | 1976 | 108 | 0.000 |
Why?
|
| Peritoneal Dialysis | 1 | 1977 | 159 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1990 | 9310 | 0.000 |
Why?
|
| Alcoholism | 1 | 1983 | 1972 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1976 | 1756 | 0.000 |
Why?
|
| Creatinine | 1 | 1977 | 1895 | 0.000 |
Why?
|
| Psychological Tests | 1 | 1953 | 639 | 0.000 |
Why?
|
| Iron Isotopes | 1 | 1969 | 19 | 0.000 |
Why?
|
| Cell Division | 1 | 1977 | 4457 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1969 | 306 | 0.000 |
Why?
|
| Deuterium | 1 | 1969 | 106 | 0.000 |
Why?
|
| Models, Structural | 1 | 1969 | 340 | 0.000 |
Why?
|
| Hemoglobins, Abnormal | 1 | 1969 | 118 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1969 | 339 | 0.000 |
Why?
|
| Metabolism | 1 | 1969 | 193 | 0.000 |
Why?
|
| Renal Dialysis | 1 | 1977 | 1795 | 0.000 |
Why?
|
| RNA, Bacterial | 1 | 1969 | 393 | 0.000 |
Why?
|
| Porphyrins | 1 | 1969 | 352 | 0.000 |
Why?
|
| RNA, Transfer | 1 | 1969 | 289 | 0.000 |
Why?
|
| Stress, Physiological | 1 | 1953 | 1403 | 0.000 |
Why?
|
| Hospitalization | 1 | 1983 | 10708 | 0.000 |
Why?
|
| Temperature | 1 | 1969 | 2224 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 1977 | 4218 | 0.000 |
Why?
|
| Stress, Psychological | 1 | 1953 | 4488 | 0.000 |
Why?
|
| Pyridines | 1 | 1969 | 2875 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1953 | 6826 | 0.000 |
Why?
|
| Hypertension | 1 | 1953 | 8532 | 0.000 |
Why?
|
| Liver | 1 | 1969 | 7512 | 0.000 |
Why?
|